Shree Ganesh Bio-Tech
0.60
-0.01(-1.64%)
Market Cap₹23.90 Cr
PE Ratio61.00
IndustryHealthcare
Company Performance:
1D-1.64%
1M-4.76%
6M-4.76%
1Y-31.82%
5Y-90.02%
View Company Insightsright
More news about Shree Ganesh Bio-Tech
25Jul 25
Shree Ganesh Biotech Reports 37.5% Jump in Net Profit for Quarter Ended June
Shree Ganesh Bio-Tech (India) Limited reported a net profit of Rs. 32.70 lacs for Q1, up 37.5% year-over-year, despite a 61.1% decline in revenue to Rs. 138.36 lacs. Total income fell 54.2% to Rs. 179.89 lacs, while expenses were reduced by 60.1% to Rs. 147.19 lacs. The company maintained its EPS at Rs. 0.01. The Board of Directors approved these unaudited financial results on July 25.
 no imag found
Shree Ganesh Bio-Tech
0.60
-0.01
(-1.64%)
1 Year Returns:-31.82%
Industry Peers
Anthem Biosciences
773.10
(+1.52%)
Advanced Enzyme Tech
372.00
(+1.35%)
CCME Global
100.30
(-4.97%)
Vivo Bio Tech
24.28
(-0.70%)